Dietary glycine protects from chemotherapy-induced hepatotoxicity

Amino Acids

Volumn 40, Issue 4, 2011, Pages 1139-1150

  Mikalauskas, Saulius ^a,b   Mikalauskiene, Laura ^a   Bruns, Helge ^a   Nickkholgh, Arash ^a   Hoffmann, Katrin ^a   Longerich, Thomas ^a   Strupas, Kestutis ^b   Büchler, Markus W ^a   Schemmer, Peter ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b VILNIUS UNIVERSITY   (Lithuania)

Author keywords

Chemotherapy; Glycine; In vivo microscopy; Kupffer cell dependent liver injury; Leukocyte endothelium interaction; Steatosis

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; FLUOROURACIL; FOLINIC ACID; GLYCINE; INDUCIBLE NITRIC OXIDE SYNTHASE; IRINOTECAN; OXALIPLATIN;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CANCER CHEMOTHERAPY; CONTROLLED STUDY; FATTY LIVER; FEMALE; KUPFFER CELL; LEUKOCYTE ADHERENCE; LIVER CIRCULATION; LIVER PERFUSION; LIVER PROTECTION; LIVER TOXICITY; MICROCIRCULATION; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANIMALS; ANTINEOPLASTIC AGENTS; CAMPTOTHECIN; COLORECTAL NEOPLASMS; DIETARY SUPPLEMENTS; DRUG TOXICITY; DRUG-INDUCED LIVER INJURY; FATTY LIVER; FEMALE; FLUOROURACIL; GLYCINE; IMMUNOHISTOCHEMISTRY; KUPFFER CELLS; LEUCOVORIN; LIVER; MICROCIRCULATION; NEOADJUVANT THERAPY; NITRIC OXIDE SYNTHASE TYPE II; ORGANOPLATINUM COMPOUNDS; PHAGOCYTOSIS; RATS; RATS, SPRAGUE-DAWLEY; TRANSAMINASES;

ANIMALIA; RATTUS;

EID: 79954445702     PISSN: 09394451     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00726-010-0737-6     Document Type: Article

References (59)

1. EK Abdalla J Vauthey 2008 Chemotherapy prior to hepatic resection for colorectal liver metastases: helpful until harmful? Dig Surg 25 421 429 19212114 10.1159/000184733 1:CAS:528:DC%2BD1MXhslyntrk%3D
2. JG Altin FL Bygrave 1988 Non-parenchymal cells as mediators of physiological responses in liver Mol Cell Biochem 83 3 14 3065613 10.1007/BF00223193 1:CAS:528:DyaL1cXls1elsr0%3D
3. HU Bergmeyer 1972 Standardization of enzyme assays Clin Chem 18 1305 1311 4652827 1:CAS:528:DyaE3sXjvFOluw%3D%3D
4. M Bilzer A Baron R Schauer C Steib S Ebensberger AL Gerbes 2002 Glutathione treatment protects the rat liver against injury after warm ischemia and Kupffer cell activation Digestion 66 49 57 12379815 10.1159/000064415 1:CAS:528:DC%2BD38XnvV2ktb4%3D (Pubitemid 36151290)
5. DC D'Souza R Gil K Cassello K Morrissey D Abi-Saab J White R Sturwold A Bennett LP Karper E Zuzarte DS Charney JH Krystal 2000 IV glycine and oral D-cycloserine effects on plasma and CSF amino acids in healthy humans Biol Psychiatry 47 450 462 10704956 10.1016/S0006-3223(99)00133-X (Pubitemid 30110616)
6. M Duvnjak I Lerotić N Barsić V Tomasić L Virović Jukić V Velagić 2007 Pathogenesis and management issues for non-alcoholic fatty liver disease World J Gastroenterol 13 4539 4550 17729403 1:CAS:528:DC%2BD2sXhtFGksLfL (Pubitemid 47455230)
7. M Froh RG Thurman MD Wheeler 2002 Molecular evidence for a glycine-gated chloride channel in macrophages and leukocytes Am J Physiol Gastrointest Liver Physiol 283 G856 G863 12223345 1:CAS:528:DC%2BD38XotV2qs7g%3D (Pubitemid 35033928)
8. Goldberg RM, Rothenberg ML, Van Cutsem E, Benson AB, Blanke CD, Diasio RB, Grothey A, Lenz H, Meropol NJ, Ramanathan RK, Becerra CHR, Wickham R, Armstrong D, Viele C (2007) The continuum of care: a paradigm for the management of metastatic colorectal cancer. Oncologist 12:38-50 (Pubitemid 46143501)
9. X Guan G Dei-Anane R Liang M Gross A Nickkholgh M Kern J Ludwig M Zeier MW Büchler J Schmidt P Schemmer 2008 Donor preconditioning with taurine protects kidney grafts from injury after experimental transplantation J Surg Res 146 127 134 18061615 10.1016/j.jss.2007.06.014 1:CAS:528:DC%2BD1cXksVaiu7g%3D (Pubitemid 351442941)
10. RY Gundersen P Vaagenes T Breivik F Fonnum PK Opstad 2005 Glycine: an important neurotransmitter and cytoprotective agent Acta Anaesthesiol Scand 49 1108 1116 16095452 10.1111/j.1399-6576.2005.00786.x 1:CAS:528:DC%2BD2MXhtVKgt7rP (Pubitemid 41192460)
11. BG Harbrecht M Perpetua M Fulmer B Zhang 2004 Glucagon regulates hepatic inducible nitric oxide synthesis in vivo Shock 22 157 162 15257089 10.1097/01.shk.0000131579.22409.33 1:CAS:528:DC%2BD2cXmslemtbk%3D (Pubitemid 40228194)
12. U Heresco-Levy DC Javitt M Ermilov C Mordel G Silipo M Lichtenstein 1999 Efficacy of high-dose glycine in the treatment of enduring negative symptoms of schizophrenia Arch Gen Psychiatry 56 29 36 9892253 10.1001/archpsyc.56.1.29 1:CAS:528:DyaK1MXhtVyrsbY%3D (Pubitemid 29055047)
13. A Hribaschek R Kuhn M Pross F Meyer J Fahlke K Ridwelski C Boltze H Lippert 2006 Intraperitoneal versus intravenous CPT-11 given intra- and postoperatively for peritoneal carcinomatosis in a rat model Surg Today 36 57 62 16378195 10.1007/s00595-004-3096-7 1:CAS:528:DC%2BD2MXhtlGhsLvL (Pubitemid 43015856)
14. K Ikejima W Qu RF Stachlewitz RG Thurman 1997 Kupffer cells contain a glycine-gated chloride channel Am J Physiol 272 G1581 G1586 9227496 1:CAS:528:DyaK2sXktlOhu7c%3D
15. H Jaeschke A Farhood 1991 Neutrophil and Kupffer cell-induced oxidant stress and ischemia-reperfusion injury in rat liver Am J Physiol 260 G355 G362 2003603 1:CAS:528:DyaK3MXhs1Wrt7g%3D
16. N Kemeny 2007 Presurgical chemotherapy in patients being considered for liver resection Oncologist 12 825 839 17673614 10.1634/theoncologist.12-7-825 1:CAS:528:DC%2BD2sXpslerur4%3D (Pubitemid 47328226)
17. AZ Khan G Morris-Stiff M Makuuchi 2009 Patterns of chemotherapy-induced hepatic injury and their implications for patients undergoing liver resection for colorectal liver metastases J Hepatobiliary Pancreat Surg 16 137 144 19093069 10.1007/s00534-008-0016-z
18. M Kincius R Liang A Nickkholgh K Hoffmann C Flechtenmacher E Ryschich CN Gutt M Gebhard J Schmidt MW Buchler P Schemmer 2007 Taurine protects from liver injury after warm ischemia in rats: the role of Kupffer cells Eur Surg Res 39 275 283 17519554 10.1159/000102982 1:CAS:528:DC%2BD2sXpt1KjsLs%3D (Pubitemid 47294438)
19. SP Luntz K Unnebrink M Seibert-Grafe H Bunzendahl TW Kraus MW Büchler E Klar P Schemmer 2005 HEGPOL: randomized, placebo controlled, multicenter, double-blind clinical trial to investigate hepatoprotective effects of glycine in the postoperative phase of liver transplantation [ISRCTN69350312] BMC Surg 5 18 16105183 10.1186/1471-2482-5-18 (Pubitemid 44971298)
20. G Masi F Loupakis L Pollina E Vasile S Cupini S Ricci IM Brunetti R Ferraldeschi G Naso F Filipponi A Pietrabissa O Goletti G Baldi L Fornaro M Andreuccetti A Falcone 2009 Long-term outcome of initially unresectable metastatic colorectal cancer patients treated with 5-fluorouracil/leucovorin, oxaliplatin, and irinotecan (folfoxiri) followed by radical surgery of metastases Ann Surg 249 420 425 19247029 10.1097/SLA.0b013e31819a0486
21. MD Menger S Pelikan D Steiner K Messmer 1992 Microvascular ischemia-reperfusion injury in striated muscle: significance of "reflow paradox" Am J Physiol 263 H1901 H1906 1282785 1:CAS:528: DyaK3sXpvFChsw%3D%3D (Pubitemid 23030746)
22. G Morris-Stiff Y Tan JN Vauthey 2008 Hepatic complications following preoperative chemotherapy with oxaliplatin or irinotecan for hepatic colorectal metastases Eur J Surg Oncol 34 609 614 17764887 1:STN:280:DC%2BD1czitFWnsA%3D%3D (Pubitemid 351671976)
23. B Nordlinger H Sorbye B Glimelius GJ Poston PM Schlag P Rougier WO Bechstein JN Primrose ET Walpole M Finch-Jones D Jaeck D Mirza RW Parks L Collette M Praet U Bethe E Van Cutsem W Scheithauer T Gruenberger 2008 Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (eortc intergroup trial 40983): a randomised controlled trial Lancet 371 1007 1016 18358928 10.1016/S0140-6736(08)60455-9 1:CAS:528:DC%2BD1cXjs1Sltbg%3D (Pubitemid 351392040)
24. B Nordlinger E Van Cutsem T Gruenberger B Glimelius G Poston P Rougier A Sobrero M Ychou 2009 Combination of surgery and chemotherapy and the role of targeted agents in the treatment of patients with colorectal liver metastases: recommendations from an expert panel Ann Oncol 20 985 992 19153115 10.1093/annonc/mdn735 1:STN:280:DC%2BD1MzmvFyjtg%3D%3D
25. AA Parikh B Gentner T Wu SA Curley LM Ellis J Vauthey 2003 Perioperative complications in patients undergoing major liver resection with or without neoadjuvant chemotherapy J Gastrointest Surg 7 1082 1088 14675719 10.1016/j.gassur.2003.08.005 (Pubitemid 37526731)
26. K Petzke V Albrecht H Zybilski 1986 The influence of high glycine diets on the activity of glycine-catabolizing enzymes and on glycine catabolism in rats J Nutr 116 742 3701456 1:CAS:528:DyaL28XktVGmt7c%3D
27. S Post P Palma M Rentsch AP Gonzalez MD Menger 1993 Differential impact of Carolina rinse and University of Wisconsin solutions on microcirculation, leukocyte adhesion, Kupffer cell activity and biliary excretion after liver transplantation Hepatology 18 1490 1497 8244275 1:CAS:528:DyaK2cXhtVWis7w%3D (Pubitemid 23348441)
28. C Pozzo C Barone 2008 Recurrent disease four years after surgery and adjuvant chemotherapy Cancer Treat Rev 34 Suppl 2 8S 11S 10.1016/S0305-7372(08) 70003-3
29. C Pozzo C Barone NE Kemeny 2008 Advances in neoadjuvant therapy for colorectal cancer with liver metastases Cancer Treat Rev 34 293 301 18291590 10.1016/j.ctrv.2008.01.004 1:CAS:528:DC%2BD1cXmtlWiurw%3D
30. 2+ due to vasoactive mediators in hepatic parenchymal cells Am J Physiol Gastrointest Liver Physiol 283 G1249 G1256 12388211 1:CAS:528:DC%2BD38XpslGisrw%3D (Pubitemid 35351111)
31. CA Rivera BU Bradford KJ Hunt Y Adachi LW Schrum DR Koop ER Burchardt RA Rippe RG Thurman 2001 Attenuation of CCl(4)-induced hepatic fibrosis by GDCl(3) treatment or dietary glycine Am J Physiol Gastrointest Liver Physiol 281 G200 G207 11408273 1:CAS:528:DC%2BD3MXltVKhtbs%3D
32. RA Roberts PE Ganey C Ju LM Kamendulis I Rusyn JE Klaunig 2007 Role of the Kupffer cell in mediating hepatic toxicity and carcinogenesis Toxicol Sci 96 2 15 17122412 10.1093/toxsci/kfl173 1:CAS:528:DC%2BD2sXhvFWmtrg%3D (Pubitemid 46323203)
33. ML Rose CA Rivera BU Bradford LM Graves RC Cattley R Schoonhoven JA Swenberg RG Thurman 1999 Kupffer cell oxidant production is central to the mechanism of peroxisome proliferators Carcinogenesis 20 27 33 9934846 10.1093/carcin/20.1.27 1:CAS:528:DyaK1MXmslClsw%3D%3D (Pubitemid 29033841)
34. RB Rosse SK Theut M Banay-Schwartz M Leighton E Scarcella CG Cohen SI Deutsch 1989 Glycine adjuvant therapy to conventional neuroleptic treatment in schizophrenia: an open-label, pilot study Clin Neuropharmacol 12 416 424 2611765 10.1097/00002826-198910000-00006 1:STN:280:DyaK3c7isVemtQ%3D%3D (Pubitemid 20008765)
35. P Schemmer R Schoonhoven JA Swenberg H Bunzendahl RG Thurman 1998 Gentle in situ liver manipulation during organ harvest decreases survival after rat liver transplantation: role of Kupffer cells Transplantation 65 1015 1020 9583858 10.1097/00007890-199804270-00001 1:STN:280:DyaK1c3ktlaitA%3D%3D (Pubitemid 28208417)
36. P Schemmer HD Connor GE Arteel JA Raleigh H Bunzendahl RP Mason RG Thurman 1999 Reperfusion injury in livers due to gentle in situ organ manipulation during harvest involves hypoxia and free radicals J Pharmacol Exp Ther 290 235 240 10381781 1:CAS:528:DyaK1MXktFKisLk%3D (Pubitemid 29302325)
37. P Schemmer R Liang M Kincius C Flechtenmacher H Bunzendahl CN Gutt A Mehrabi M Gebhard MW Büchler TW Kraus 2005 Taurine improves graft survival after experimental liver transplantation Liver Transpl 11 950 959 16035074 10.1002/lt.20501 (Pubitemid 41122453)
38. Schindler G, Kincius M, Liang R, Backhaus J, Zorn M, Flechtenmacher C, Gebhard M, Buchler MW, Schemmer P (2009) Fundamental efforts toward the development of a therapeutic cocktail with a manifold ameliorative effect on hepatic ischemia/reperfusion injury. Microcirculation, pp 1-10
39. RF Stachlewitz V Seabra B Bradford CA Bradham I Rusyn D Germolec RG Thurman 1999 Glycine and uridine prevent D-galactosamine hepatotoxicity in the rat: role of Kupffer cells Hepatology 29 737 745 10051475 10.1002/hep.510290335 1:CAS:528:DyaK1MXhvFyjs78%3D (Pubitemid 29109587)
40. S Suzuki LH Toledo-Pereyra 1994 Interleukin 1 and tumor necrosis factor production as the initial stimulants of liver ischemia and reperfusion injury J Surg Res 57 253 258 7518017 10.1006/jsre.1994.1140 1:CAS:528:DyaK2cXmtVeiu78%3D (Pubitemid 24262396)
41. C Szabó GJ Southan C Thiemermann 1994 Beneficial effects and improved survival in rodent models of septic shock with S-methylisothiourea sulfate, a potent and selective inhibitor of inducible nitric oxide synthase Proc Natl Acad Sci USA 91 12472 12476 7528923 10.1073/pnas.91.26.12472
42. D Tamandl B Gruenberger B Herberger K Kaczirek T Gruenberger 2009 Surgery after neoadjuvant chemotherapy for colorectal liver metastases is safe and feasible in elderly patients J Surg Oncol 100 364 371 19235181 10.1002/jso.21259
43. A Teufel S Steinmann J Siebler C Zanke H Hohl B Adami M Schroeder O Klein T Höhler PR Galle M Heike M Moehler 2004 Irinotecan plus folinic acid/continuous 5-fluorouracil as simplified bimonthly FOLFIRI regimen for first-line therapy of metastatic colorectal cancer BMC Cancer 4 38 15265233 10.1186/1471-2407-4-38 (Pubitemid 40180248)
44. C Tournigand T André E Achille G Lledo M Flesh D Mery-Mignard E Quinaux C Couteau M Buyse G Ganem B Landi P Colin C Louvet A de Gramont 2004 FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study J Clin Oncol 22 229 237 14657227 10.1200/JCO.2004.05.113 1:CAS:528:DC%2BD2cXpsVKit7w%3D (Pubitemid 41095086)
45. S Uhlmann D Uhlmann HU Spiegel 1999 Evaluation of hepatic microcirculation by in vivo microscopy J Invest Surg 12 179 193 10501077 10.1080/089419399272458 1:STN:280:DyaK1MvivFWrtw%3D%3D (Pubitemid 29403550)
46. J Vauthey TM Pawlik D Ribero T Wu D Zorzi PM Hoff HQ Xiong C Eng GY Lauwers M Mino-Kenudson M Risio A Muratore L Capussotti SA Curley EK Abdalla 2006 Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases J Clin Oncol 24 2065 2072 16648507 10.1200/JCO.2005.05.3074 1:CAS:528:DC%2BD28Xlt1amurY%3D (Pubitemid 46622116)
47. TA Vos AS Gouw PA Klok R Havinga H van Goor S Huitema H Roelofsen F Kuipers PL Jansen H Moshage 1997 Differential effects of nitric oxide synthase inhibitors on endotoxin-induced liver damage in rats Gastroenterology 113 1323 1333 9322528 10.1053/gast.1997.v113.pm9322528 1:CAS:528:DyaK2sXmslOlsbc%3D (Pubitemid 27418987)
48. JM Weinberg JA Davis M Abarzua T Rajan 1987 Cytoprotective effects of glycine and glutathione against hypoxic injury to renal tubules J Clin Invest 80 1446 1454 2890657 10.1172/JCI113224 1:CAS:528:DyaL1cXjsFyrtw%3D%3D (Pubitemid 18027789)
49. FKS Welsh HS Tilney PP Tekkis TG John M Rees 2007 Safe liver resection following chemotherapy for colorectal metastases is a matter of timing Br J Cancer 96 1037 1042 17353923 10.1038/sj.bjc.6603670 1:STN:280: DC%2BD2s3gt12jtA%3D%3D (Pubitemid 46608314)
50. MD Wheeler 2003 Endotoxin and Kupffer cell activation in alcoholic liver disease Alcohol Res Health 27 300 306 15540801 (Pubitemid 40685569)
51. MD Wheeler K Ikejema N Enomoto RF Stacklewitz V Seabra Z Zhong M Yin P Schemmer ML Rose I Rusyn B Bradford RG Thurman 1999 Glycine: a new anti-inflammatory immunonutrient Cell Mol Life Sci 56 843 856 11212343 10.1007/s000180050030 1:CAS:528:DyaK1MXotVOnurk%3D
52. M Wheeler RF Stachlewitz S Yamashina K Ikejima AL Morrow RG Thurman 2000 Glycine-gated chloride channels in neutrophils attenuate calcium influx and superoxide production FASEB J 14 476 484 10698962 1:CAS:528:DC%2BD3cXisFyhtL4%3D (Pubitemid 30143166)
53. MD Wheeler ML Rose S Yamashima N Enomoto V Seabra J Madren RG Thurman 2000 Dietary glycine blunts lung inflammatory cell influx following acute endotoxin Am J Physiol Lung Cell Mol Physiol 279 L390 L398 10926563 1:CAS:528:DC%2BD3cXmtFyis7k%3D
54. JJ Widmann RS Cotran HD Fahimi 1972 Mononuclear phagocytes (Kupffer cells) and endothelial cells identification of two functional cell types in rat liver sinusoids by endogenous peroxidase activity J Cell Biol 52 159 170 4331297 10.1083/jcb.52.1.159 1:STN:280:DyaE38%2FmtFOiug%3D%3D
55. H Yano S Kinoshita S Kira 2004 Effects of acute moderate exercise on the phagocytosis of Kupffer cells in rats Acta Physiol Scand 182 151 160 15450111 10.1111/j.1365-201X.2004.01343.x 1:CAS:528:DC%2BD2cXosl2htrY%3D (Pubitemid 39371862)
56. HS Younis AR Parrish I Glenn Sipes 2003 The role of hepatocellular oxidative stress in Kupffer cell activation during 1,2-dichlorobenzene-induced hepatotoxicity Toxicol Sci 76 201 211 12915711 10.1093/toxsci/kfg207 1:CAS:528:DC%2BD3sXosVeqsLs%3D (Pubitemid 37361899)
57. Z Zhong S Jones RG Thurman 1996 Glycine minimizes reperfusion injury in a low-flow, reflow liver perfusion model in the rat Am J Physiol 270 G332 G338 8779976 1:CAS:528:DyaK28XhsFyrsLs%3D
58. Z Zhong MD Wheeler X Li M Froh P Schemmer M Yin H Bunzendaul B Bradford JJ Lemasters 2003 L-glycine: a novel antiinflammatory, immunomodulatory, and cytoprotective agent Curr Opin Clin Nutr Metab Care 6 229 240 12589194 10.1097/00075197-200303000-00013 1:CAS:528:DC%2BD3sXislejsrw%3D (Pubitemid 40674528)
59. D Zorzi A Laurent TM Pawlik GY Lauwers J Vauthey EK Abdalla 2007 Chemotherapy-associated hepatotoxicity and surgery for colorectal liver metastases Br J Surg 94 274 286 17315288 10.1002/bjs.5719 1:CAS:528: DC%2BD2sXkt12nt7s%3D (Pubitemid 46423843)